PhaseFolio brings risk-adjusted NPV (rNPV) modeling and biotech diligence into Claude Code. Value clinical-stage assets across the full development pipeline, look up published probabilities of success by indication, modality, and biomarker, scan competitive landscapes from ClinicalTrials.gov and FDA Drugs@FDA, and verify signed PhaseFolio export signatures - all from natural-language prompts. Every output ships with embedded engine, methodology, and benchmark versions, so any number you produce is reproducible by a counterparty reviewing your work.